While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
If a person has low B12 levels or poor B12 absorption, they may notice improvement relatively soon after treatment
Chemical Information CAS No
Alternatively, when cancer cells use GSH as a cysteine source, they rely less on these pathways (that is, xCT and TXNRD1)
In the present study, an efficient method was developed for rapid identification and characterization of GSH-trapped metabolites with a single run using a quadrupole orbitrap high-resolution mass spectrometer
Packaging: 60 capsules